Abstract
The method of determining the pharmacological properties of a chemical compound based on the prediction of the results of preclinical laboratory tests was presented. The results of preclinical trials are used to obtain information about the safety of the product under development both for the purposes of preclinical studies and throughout the entire drug cycle. The proposed approach makes it possible to determine the presence of specific pharmacological properties of chemicals in the compound intended for preclinical testing. The method includes conducting a factor analysis in order to identify the most significant features that affect the pharmacological activity of the observed synthesized chemical compound. Further, on the basis of the selected factors, a predictive model is built. The model uses data on the quantitative characteristics of the substance and a description of the target involved in the study. The developed approach essentially decreases the period of preclinical studies of new medicines
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Bulletin of the Saint Petersburg State Institute of Technology (Technical University)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
